Plasma Concentration Studies
Ipamorelin
NNC 26-0161
CAS: 170851-70-4
A 5-amino acid pentapeptide that selectively stimulates growth hormone release through ghrelin receptor (GHSR-1a) activation without affecting cortisol, ACTH, or prolactin levels in preclinical and clinical research. Premium Research Peptide.
99%+ Purity
Purity Tested
Research Use Only
Laboratory Use
Peptide Profile
Peptide Type
Certificate of Analysis
Third Party Tested by Freedom Diagnostics
Compound Information
Technical specifications
What Is Ipamorelin?
Stability Information
Freeze for storage
Refrigerate after reconstitution
Protect from light
Lyophilized (powder)
2-8°C for 24+ months
Reconstituted
2-8°C for 2-4 weeks
Sources & References
Peer-reviewed research
European Journal of Endocrinology .1998
Ipamorelin, the first selective growth hormone secretagogue
Raun K, Hansen BS, Johansen NL et al.
View Source
British Journal of Pharmacology .1999
Pharmacokinetic and pharmacodynamic study of the growth hormone secretagogue Ipamorelin in humans
Johansen PB, Segev Y, Landau D et al.
View Source
Growth Hormone & IGF Research .2001
Ipamorelin stimulates longitudinal bone growth in rats
Andersen NB, Johansen PB, Skjærbæk C et al.
View Source
Journal of Gastrointestinal Surgery .2014
Ipamorelin (a ghrelin agonist) for the treatment of post-operative ileus: a randomized, double-blind, placebo-controlled, phase II study
Beck DE, Sweeney WB, McCarter MD et al.
View Source
Translational Andrology and Urology .2018
A Review of Growth Hormone Secretagogues
Sigalos JT, Pastuszak AW
View Source
